Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauro Papotti

Showing results (151-160 of 386) with videos related to

Pageof 39
Sort By:
La Radiologia Medica|May 2, 2015
Safety and diagnostic performance of image-guided lung biopsy in the targeted therapy eraMarco Busso, Diego Sardo, Irene Garetto, et al.
Annals of Surgery|October 27, 2009
The usefulness of preoperative dual-phase 99mTc MIBI-scintigraphy and IO-PTH assay in the treatment of secondary and tertiary hyperparathyroidismGuido Gasparri, Michele Camandona, Ugo Bertoldo, et al.
Oncotarget|July 9, 2016
Dasatinib modulates sensitivity to pemetrexed in malignant pleural mesothelioma cell linesValentina Monica, Marco Lo Iacono, Enrico Bracco, et al.
Endocrine Pathology|January 12, 2021
A Subset of Large Cell Neuroendocrine Carcinomas in the Gastroenteropancreatic Tract May Evolve from Pre-existing Well-Differentiated Neuroendocrine TumorsGiuseppe Pelosi, Fabrizio Bianchi, Elisa Dama, et al.
Human Pathology|December 6, 2016
Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinomaEleonora Duregon, Rocco Cappellesso, Valeria Maffeis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 4, 2008
Human ASH1 expression in prostate cancer with neuroendocrine differentiationIda Rapa, Paolo Ceppi, Enrico Bollito, et al.
Endocrine Pathology|May 14, 2020
Amyloid-Rich Pancreatic Neuroendocrine Tumors: a Potential Diagnostic Pitfall in Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology (EUS-FNAC)Alessandro Gambella, Enrico Costantino Falco, Jasna Metovic, et al.
The Journal of Urology|February 13, 2014
The roles of multiparametric magnetic resonance imaging, PCA3 and prostate health index-which is the best predictor of prostate cancer after a negative biopsy?Francesco Porpiglia, Filippo Russo, Matteo Manfredi, et al.
Virchows Archiv : an International Journal of Pathology|January 6, 2017
Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are appliedAlessandra Fabbri, Mara Cossa, Angelica Sonzogni, et al.
European Journal of Endocrinology|February 7, 2004
Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell linesPaola Cassoni, Corrado Ghé, Tiziana Marrocco, et al.
Pageof 39

Showing results (151-160 of 386) with videos related to

Sort By:
Pageof 39
La Radiologia Medica|May 2, 2015
Safety and diagnostic performance of image-guided lung biopsy in the targeted therapy eraMarco Busso, Diego Sardo, Irene Garetto, et al.
Annals of Surgery|October 27, 2009
The usefulness of preoperative dual-phase 99mTc MIBI-scintigraphy and IO-PTH assay in the treatment of secondary and tertiary hyperparathyroidismGuido Gasparri, Michele Camandona, Ugo Bertoldo, et al.
Oncotarget|July 9, 2016
Dasatinib modulates sensitivity to pemetrexed in malignant pleural mesothelioma cell linesValentina Monica, Marco Lo Iacono, Enrico Bracco, et al.
Endocrine Pathology|January 12, 2021
A Subset of Large Cell Neuroendocrine Carcinomas in the Gastroenteropancreatic Tract May Evolve from Pre-existing Well-Differentiated Neuroendocrine TumorsGiuseppe Pelosi, Fabrizio Bianchi, Elisa Dama, et al.
Human Pathology|December 6, 2016
Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinomaEleonora Duregon, Rocco Cappellesso, Valeria Maffeis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 4, 2008
Human ASH1 expression in prostate cancer with neuroendocrine differentiationIda Rapa, Paolo Ceppi, Enrico Bollito, et al.
Endocrine Pathology|May 14, 2020
Amyloid-Rich Pancreatic Neuroendocrine Tumors: a Potential Diagnostic Pitfall in Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology (EUS-FNAC)Alessandro Gambella, Enrico Costantino Falco, Jasna Metovic, et al.
The Journal of Urology|February 13, 2014
The roles of multiparametric magnetic resonance imaging, PCA3 and prostate health index-which is the best predictor of prostate cancer after a negative biopsy?Francesco Porpiglia, Filippo Russo, Matteo Manfredi, et al.
Virchows Archiv : an International Journal of Pathology|January 6, 2017
Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are appliedAlessandra Fabbri, Mara Cossa, Angelica Sonzogni, et al.
European Journal of Endocrinology|February 7, 2004
Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell linesPaola Cassoni, Corrado Ghé, Tiziana Marrocco, et al.
Pageof 39